Table 1.

The six lung cancer cases described, including the diagnosis and the presumed standard guideline-recommended therapy

Case 1: Stage I NSCLC	New diagnosis of stage I, inoperable, peripherally located NSCLC
	Institutional standard fractionation of SBRT according to NCCN: 3–4 Fx total dose 45–54 Gy
Case 2: Stage III NSCLC	Locally advanced stage IIIA (bulky N2) NSCLC
	Standard fractionation of radiochemotherapy: 30–33 Fx over 6–6.5 weeks, total dose 60–66 Gy
Case 3: PORT NSCLC	Resected N2 (multi-station and extra nodal spread) NSCLC
	Standard fractionation of radiotherapy: 27 Fx over 5.5 weeks, total dose 54 Gy
Case 4: LS SCLC	SCLC, limited stage
	Standard fractionation of radiochemotherapy: 30 Fx over 3 weeks, BID, total dose 45 Gy, OR 33 Fx over 6.5 weeks, total dose 66 Gy
Case 5: PCI LS SCLC	PCI for SCLC limited stage after good response to radiochemotherapy
	Standard fractionation of radiotherapy: 10 Fx over 2 weeks, total dose 25 Gy
Case 6: palliative NSCLC	Palliative metastatic NSCLC with failure after first-line chemo-IO combination and symptoms due to mediastinal/hilar disease progression and severe cough and moderate dyspnea
	Standard fractionation of radiotherapy: 10 Fx over 2 weeks, total dose 30 Gy